Business Breakdowns | 16 June 2021 | 1h 09m | Listen Later | iTunes
Interview breaking down Moderna and its innovative RNA platform that was one of the first to develop a covid-19 vaccine. Starts with a primer on the biotech industry, genetic modification, and how Moderna’s platform represents a breakthrough in the industry. Then discusses what differentiates Moderna’s business model, how Moderna’s science could lead to faster and higher efficacy drug development, with key takeaways for investors and operators.